These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9291068)

  • 1. Technical considerations for acquiring and processing indium-111 capromab pendetide images.
    Williams BS; Hinkle GH; Lamatrice RA; Fry JP; Loesch JA; Olsen JO
    J Nucl Med Technol; 1997 Sep; 25(3):205-16. PubMed ID: 9291068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer.
    Hardie AD; Rieter WJ; Bradshaw ML; Gordon LL; Young MA; Keane TE
    World J Urol; 2013 Dec; 31(6):1327-32. PubMed ID: 23595605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in SPECT/CT imaging of prostate cancer.
    Seo Y; Franc BL; Hawkins RA; Wong KH; Hasegawa BH
    Technol Cancer Res Treat; 2006 Aug; 5(4):329-36. PubMed ID: 16866563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-isotope protocol for indium-111 capromab pendetide monoclonal antibody imaging.
    Kelty NL; Holder LE; Khan SH
    J Nucl Med Technol; 1998 Sep; 26(3):174-7. PubMed ID: 9755436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using vascular structure for CT-SPECT registration in the pelvis.
    Hamilton RJ; Blend MJ; Pelizzari CA; Milliken BD; Vijayakumar S
    J Nucl Med; 1999 Feb; 40(2):347-51. PubMed ID: 10025845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.
    Schuster DM; Savir-Baruch B; Nieh PT; Master VA; Halkar RK; Rossi PJ; Lewis MM; Nye JA; Yu W; Bowman FD; Goodman MM
    Radiology; 2011 Jun; 259(3):852-61. PubMed ID: 21493787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer.
    Ellis RJ; Kaminsky DA; Zhou EH; Fu P; Chen WD; Brelin A; Faulhaber PF; Bodner D
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):29-34. PubMed ID: 20961696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.
    Manyak MJ; Hinkle GH; Olsen JO; Chiaccherini RP; Partin AW; Piantadosi S; Burgers JK; Texter JH; Neal CE; Libertino JA; Wright GL; Maguire RT
    Urology; 1999 Dec; 54(6):1058-63. PubMed ID: 10604708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer.
    Tsivian M; Wright T; Price M; Mouraviev V; Madden JF; Kimura M; Wong T; Polascik TJ
    Urol Oncol; 2012; 30(2):150-4. PubMed ID: 20189846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
    Rosenthal SA; Haseman MK; Polascik TJ
    Tech Urol; 2001 Mar; 7(1):27-37. PubMed ID: 11272670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of (111)In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy.
    Kimura M; Tsivian M; Mouraviev V; Mayes JM; Price MM; Bannister MC; Madden JF; Wong TZ; Polascik TJ
    Int J Urol; 2009 Dec; 16(12):971-5. PubMed ID: 19843189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of In-111 capromab pendetide SPECT/CT in localized and metastatic prostate cancer.
    Rieter WJ; Keane TE; Ahlman MA; Ellis CT; Spicer KM; Gordon LL
    Clin Nucl Med; 2011 Oct; 36(10):872-8. PubMed ID: 21892036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer.
    Schettino CJ; Kramer EL; Noz ME; Taneja S; Padmanabhan P; Lepor H
    AJR Am J Roentgenol; 2004 Aug; 183(2):519-24. PubMed ID: 15269050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.
    Seo Y; Aparici CM; Cooperberg MR; Konety BR; Hawkins RA
    J Nucl Med; 2010 Jan; 51(1):31-6. PubMed ID: 20008977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstruction parameters for 111In-pentetreotide SPECT: variability with respect to body weight and body region.
    Massaro A; Cittadin S; Rossi F; Rampin L; Banti E; Nibale O; Rubello D
    J Nucl Med Technol; 2007 Dec; 35(4):237-41. PubMed ID: 18006596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capromab pendetide. A review of its use as an imaging agent in prostate cancer.
    Lamb HM; Faulds D
    Drugs Aging; 1998 Apr; 12(4):293-304. PubMed ID: 9571393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indium-111 capromab pendetide in the management of recurrent prostate cancer.
    Manyak MJ
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):175-81. PubMed ID: 18279057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology.
    Wong TZ; Turkington TG; Polascik TJ; Coleman RE
    AJR Am J Roentgenol; 2005 Feb; 184(2):676-80. PubMed ID: 15671397
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment. Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostate.
    Shore ND
    Urology; 2010 Nov; 76(5):1167-8; author reply 1168. PubMed ID: 21056261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.